Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gregory D. Espenan"'
Publikováno v:
Theranostics, Vol 2, Iss 1, Pp 472-480 (2012)
Aim: To study the long term benefits, toxicity and survival rate in patients with neuroendocrine tumors receiving multiple cycles of high activity In-111 Pentetreotide therapy. Moreover, our secondary aim was to evaluate the value of F-18 FDG PET-CT
Externí odkaz:
https://doaj.org/article/ebab49b9b94c4015878ea99119934b48
Autor:
Arthur Camp, Gregory D. Espenan, Anne E. Diebold, Yi-Zarn Wang, Thomas J. Maloney, D. J. Frey, Shawn J. Stafford, Eugene A. Woltering, Charles Chappuis, William W. Harkrider
Publikováno v:
Journal of the American College of Surgeons. 216:599-605
Background The aim of this study was to determine if an intraoperative injection of iodine-125−labeled methylene blue ( 125 I-MB) is a sensitive and effective method for detecting SLNs in women with breast cancer. Study Design Sixty-two women were
Autor:
Jennifer Sims-Mourtada, Ali Azhdarinia, Hitomi Saso, Eugene A. Woltering, Faramarz Ashoori, Warren H. Moore, Lowell Anthony, Farzad Torabi, Gregory D. Espenan, Ebrahim S. Delpassand
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 23:292-300
The intent of this study was to evaluate the safety and efficacy of high-activity 111In-pentetreotide in patients with neuroendocrine tumors. Thirty-two patients with pentetreotide-avid neuroendocrine tumors received therapy from August 2005 to Novem
Autor:
Jason D. Cundiff, Yi-Zarn Wang, Thomas J. Maloney, Gregory D. Espenan, Arthur Camp, Eugene A. Woltering, Jessica L. Thomson, Shawn J. Stafford, Jessica L. Wright, Joshua E. Schwimer, Catherine T. Anthony
Publikováno v:
Journal of Surgical Oncology. 94:293-297
Background Sentinel lymph node biopsy is an established alternative to complete lymph node dissection in some patients. We have developed a novel, radiolabeled methylene blue dye that may be a useful alternative to the traditional two-step procedure
Autor:
Alireza Mojtahedi, Ebrahim S. Delpassand, Eric P. Krenning, Thomas M. O'Dorisio, Jaime Simon, Edward M. Wolin, Sara Zamanian, Larry K. Kvols, Jack L. Erion, Amin Samarghandi, Robert Wolfangel, Arthur Camp, Gregory D. Espenan, Mohammadali Hamiditabar
Publikováno v:
Pancreas. 43(4)
Peptide receptor radionuclide therapy with radiolabeled somatostatin analogs is a novel method of treatment in patients with metastatic neuroendocrine tumors (NETs). For the first time in the United States, we present preliminary results of the treat
Autor:
Kambiz Kosari, Roozbeh Sharif, Jennifer Sims Mourtada, Ebrahim S. Delpassand, Amin Samarghandi, Shagufta Naqvi, Gregory D. Espenan, John E. Seng, Lowell Anthony, Omar Barakat, Sara Zamanian, Shawn MacKenzie
Publikováno v:
Theranostics
Aim: To study the long term benefits, toxicity and survival rate in patients with neuroendocrine tumors receiving multiple cycles of high activity In-111 Pentetreotide therapy. Moreover, our secondary aim was to evaluate the value of F-18 FDG PET-CT
Autor:
Gregory D. Espenan, Eugene A. Woltering, Laura Lazarus, Yi-Zarn Wang, O'Leary Jp, Thomas J. Maloney, Jason D. Cundiff, Bruce Torrance, Arthur Camp, Randy Brooks, Alan Stolier, Shawn J. Stafford
Publikováno v:
Annals of surgery. 245(2)
Sentinel lymph node biopsy was initially developed as a technique for the detection of regional lymph node metastasis in patients with melanoma by Morton et al.1 The evolution of the procedure as a means to detect the presence of axillary lymph node
Autor:
Gregory D. Espenan, M S O'Dorisio, Douglas A. Balster, J C Watson, George J. Drouant, B M Gebhardt, Thomas M. O'Dorisio, Eugene A. Woltering
Publikováno v:
British Journal of Cancer
We hypothesized that non-proliferating (quiescent) human vascular endothelial cells would not express somatostatin receptor subtype 2 (sst 2) and that this receptor would be expressed when the endothelial cells begin to grow. To test this hypothesis,
Autor:
J. Ralph Meier, James C. Watson, Luke J. Weber, Gregory D. Espenan, Thomas M. O'Dorisio, Eugene A. Woltering, Robertino Mera, M. Sue O'Dorisio, D. A. Wray, Connie McKnight, Maria C. Cuntz, Edward A. Levine
Publikováno v:
Annals of surgical oncology. 6(4)
Somatostatin receptors are present in most human breast cancers. We performed a pilot trial of intraoperative tumor-gamma detection using the radiolabeled somatostatin analog 125I-lanreotide in 13 women with 14 primary breast carcinomas.All patients
Autor:
Gregory D. Espenan, C Sharma, F. Chen, J. Nelson, M S. O'Dorisio, William A. Murphy, Joseph A. Fuselier, T M. Maloney, David H. Coy, Daniel S. Diaco, George J. Drouant, Darrell R. Fisher, Thomas M. O'Dorisio, Eugene A. Woltering
Publikováno v:
The journal of peptide research : official journal of the American Peptide Society. 53(2)
Radio-labeled somatostatin analogs have recently gained popularity as agents useful in intraoperative tumor localization, external scintigraphy and in situ radiotherapy. We have synthesized and characterized a series of novel N-terminally extended mu